SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-046410
Filing Date
2024-04-22
Accepted
2024-04-22 16:01:04
Documents
9
Period of Report
2024-06-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A alxo_def_14a_2024_proxy.htm DEF 14A 1098943
2 GRAPHIC img142714151_0.jpg GRAPHIC 148612
3 GRAPHIC img142714151_1.jpg GRAPHIC 4688
4 GRAPHIC img142714151_2.jpg GRAPHIC 8780
5 GRAPHIC img142714151_3.jpg GRAPHIC 8780
6 GRAPHIC img142714151_4.jpg GRAPHIC 54206
7 GRAPHIC img142714151_5.jpg GRAPHIC 57354
8 GRAPHIC img142714151_6.jpg GRAPHIC 127720
9 GRAPHIC img142714151_7.jpg GRAPHIC 134749
  Complete submission text file 0000950170-24-046410.txt   1844030
Mailing Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39386 | Film No.: 24861118
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)